The value of a metabolic and immune-related gene signature and adjuvant therapeutic response in pancreatic cancer
BackgroundPancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized by a dismal prognosis. Treatment outcomes exhibit substantial variability across patients, underscoring the urgent need for robust predictive models to effectively estimate survival probabilities and th...
Saved in:
| Main Authors: | Danlei Ni, Jiayi Wu, Jingjing Pan, Yajing Liang, Zihui Xu, Zhiying Yan, Kequn Xu, Feifei Wei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Genetics |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2024.1475378/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The comparison of IGFBP-5 expression level in Pancreatic ductal adenocarcinoma tumors and their normal adjacent tissues
by: Jafar Karim Ghate, et al.
Published: (2025-06-01) -
Improved Predictability of Diagnosis and Prognosis Using Serum‐ and Tissue‐Derived Extracellular Vesicles From Bulk mRNA Sequencing in Pancreatic Ductal Adenocarcinoma
by: Qian Zhu, et al.
Published: (2025-01-01) -
Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC)
by: Han Yin, et al.
Published: (2024-08-01) -
Weighted gene co-expression network analysis reveals key stromal prognostic markers in pancreatic cancer
by: G. Mantini, et al.
Published: (2024-12-01) -
Trends in the use and efficacy of adjuvant immunotherapy in muscle-invasive urothelial carcinoma
by: Shingo Hatakeyama, et al.
Published: (2025-07-01)